0000950170-23-032034.txt : 20230706
0000950170-23-032034.hdr.sgml : 20230706
20230706163037
ACCESSION NUMBER: 0000950170-23-032034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230703
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mullins Kevin Michael
CENTRAL INDEX KEY: 0001864233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40478
FILM NUMBER: 231073993
MAIL ADDRESS:
STREET 1: 4800 N. SCOTTSDALE ROAD
STREET 2: SUITE 6000
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85251
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeStance Health Group, Inc.
CENTRAL INDEX KEY: 0001845257
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 N. SCOTTSDALE ROAD
STREET 2: SUITE 6000
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85251
BUSINESS PHONE: 602-767-2100
MAIL ADDRESS:
STREET 1: 4800 N. SCOTTSDALE ROAD
STREET 2: SUITE 6000
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85251
4
1
ownership.xml
4
X0407
4
2023-07-03
0001845257
LifeStance Health Group, Inc.
LFST
0001864233
Mullins Kevin Michael
C/O LIFESTANCE HEALTH GROUP, INC.
4800 N. SCOTTSDALE ROAD, SUITE 6000
SCOTTSDALE
AZ
85251
false
true
false
false
Chief Development Officer
false
Common Stock
2023-07-03
4
S
false
54600
9.00
D
5316016
D
Common Stock
2023-07-05
4
S
false
150000
8.72
D
5166016
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.91 to $9.13 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.63 to $8.96 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
By: /s/ Ryan Pardo, Attorney-in-Fact
2023-07-06